Cardiff Oncology Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cardiff Oncology, Inc. (CRDF) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents51.4721.6616.35140.82130.9810.2011.45
Short-Term Investments40.2853.1788.92128.880.000.000.00
Cash & Short-Term Investments91.7574.82105.27140.82130.9810.2011.45
Accounts Receivable0.770.290.770.540.320.200.17
Inventory0.000.000.000.000.000.000.00
Other Current Assets2.542.305.25-0.142.06-0.970.00
Total Current Assets95.0577.41111.28146.13133.3611.3512.77
Non-Current Assets
Property, Plant & Equipment (Net)2.072.953.523.180.970.701.30
Other Non-Current Assets0.071.281.390.24-1.770.160.10
Total Non-Current Assets2.144.234.913.42-0.800.851.41
Total Assets97.1981.64116.19149.54134.7313.0914.17
Current Liabilities
Accounts Payable4.821.971.965.975.223.922.44
Short-Term Debt0.710.000.000.000.000.000.00
Accrued Liabilities7.905.055.182.683.460.000.00
Other Current Liabilities7.902.741.850.040.040.000.00
Total Current Liabilities13.4310.447.816.566.124.782.92
Non-Current Liabilities
Long-Term Debt0.811.462.042.570.010.860.00
Other Non-Current Liabilities0.000.000.000.000.160.130.04
Total Non-Current Liabilities0.811.462.042.570.450.991.16
Total Liabilities14.2411.909.859.136.575.784.09
Stockholders' Equity
Common Stock0.010.000.000.000.000.000.00
Retained Earnings-384.18-339.54-298.10-259.95-231.50-208.90-192.19
Accumulated Other Comprehensive Income0.03-0.07-0.40-0.14-2.170.000.00
Additional Paid-in Capital467.09409.34404.83400.50361.82217.17202.27
Shares Outstanding66.5244.6844.6841.960.000.000.00
Total Stockholders' Equity82.9569.74106.34140.56130.338.2810.08
Total Liabilities & Equity97.1981.64116.19149.54134.7313.0914.17